Compare ACA & PTGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ACA | PTGX |
|---|---|---|
| Founded | 2018 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Metal Fabrications | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.5B | 6.4B |
| IPO Year | 2018 | 2016 |
| Metric | ACA | PTGX |
|---|---|---|
| Price | $135.84 | $112.86 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 13 |
| Target Price | ★ $120.00 | $108.23 |
| AVG Volume (30 Days) | 244.9K | ★ 531.5K |
| Earning Date | 04-30-2026 | 05-07-2026 |
| Dividend Yield | ★ 0.17% | N/A |
| EPS Growth | ★ 121.99 | N/A |
| EPS | ★ 0.77 | 0.05 |
| Revenue | ★ $2,883,400,000.00 | N/A |
| Revenue This Year | $5.26 | $874.25 |
| Revenue Next Year | $6.49 | N/A |
| P/E Ratio | ★ $175.74 | $2,231.60 |
| Revenue Growth | ★ 12.20 | N/A |
| 52 Week Low | $81.91 | $49.86 |
| 52 Week High | $137.76 | $114.49 |
| Indicator | ACA | PTGX |
|---|---|---|
| Relative Strength Index (RSI) | 66.33 | 63.61 |
| Support Level | $99.46 | $94.48 |
| Resistance Level | N/A | N/A |
| Average True Range (ATR) | 4.11 | 4.89 |
| MACD | 0.95 | 1.38 |
| Stochastic Oscillator | 88.44 | 92.52 |
Arcosa Inc is a manufacturer and producer of infrastructure-related products and services. It operates in three segments: Construction Products, Engineered Structures, and Transportation Products. The Construction Products segment produces and sells construction aggregates and manufactures and sells trench shields and shoring products and services for infrastructure-related projects. The Transportation Products segment manufactures and sells products for the inland waterway and rail transportation industries. The Engineered Structures segment manufactures and sells products for energy-related businesses, including structural wind towers, telecommunication structures, steel utility structures for electricity transmission and distribution, and storage and distribution containers.
Protagonist Therapeutics Inc is a biopharmaceutical company engaged in the discovery and development of peptide-based therapeutics using its proprietary technology platform. The company focuses on three therapeutic areas: inflammation and immunology, hematology, and metabolic diseases. Its pipeline includes clinical-stage and preclinical candidates such as rusfertide for polycythemia vera, icotrokinra for inflammatory diseases, and other programs targeting IL-17, obesity, and iron metabolism disorders, developed through internal research and strategic collaborations.